Published:
October 14, 2025
Author:
Justin Brodie-Kommit, PhD

The retina has been the foundational model system for developmental neurobiology for nearly three centuries. My Ph.D. research at Johns Hopkins was dedicated to shattering a 30-year-old dogma: the absolute requirement of a single transcription factor, Atoh7, for the creation of Retinal Ganglion Cells (RGCs).
For three decades, this simple model dictated that retinal stem cells followed a strict, sequential transcription factor cascade: Atoh7 was expressed in stem cells, acting as the singular switch to turn them into RGCs. The next switch was then expressed to specify cones, and so on for all seven retinal cell types. Without Atoh7, RGCs vanished, which led to a hereditary form of blindness. Published in textbooks, this model used this elegant, single-factor dependency as a broad template for all neuronal development.
My groundbreaking work, published in Science Advances, completely upended this model. We discovered that the dramatic RGC loss was a catastrophic failure of cell survival that had masked the true biology for decades. By using advanced genetic engineering to prevent cell death in the absence of Atoh7, we uncovered a stunning truth: RGC specification is not a simple cascade, but a complex, diverse population governed by a resilient regulatory network. This discovery is critical for new treatments for retinal diseases.
This scientific victory provided the two most crucial lessons I apply every day to deep tech investment:
View the pdf.

Motivated by a profound concern for vulnerable populations and ecosystems, Justin is committed to making a difference in the face of our climate crisis.